California Public Employees Retirement System’s Cyclerion Therapeutics CYCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,255
Closed -$126K 1910
2021
Q1
$126K Hold
2,255
﹤0.01% 3439
2020
Q4
$138K Sell
2,255
-45
-2% -$3.07K ﹤0.01% 3426
2020
Q3
$280K Buy
2,300
+880
+62% +$101K ﹤0.01% 3108
2020
Q2
$168K Hold
1,420
﹤0.01% 3203
2020
Q1
$75K Hold
1,420
﹤0.01% 3182
2019
Q4
$77K Sell
1,420
-245
-15% -$22.9K ﹤0.01% 3322
2019
Q3
$404K Buy
1,665
+346
+26% +$74.7K ﹤0.01% 2650
2019
Q2
$302K Buy
+1,319
New +$373K ﹤0.01% 2744

Other funds holding CYCN

California Public Employees Retirement System's CYCN Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Cyclerion Therapeutics (CYCN) in Q2 2021, closing a stake of 2,255 shares — an estimated $126K sold.

California Public Employees Retirement System first reported a position in CYCN in Q2 2019 and held it in 8 quarters. The position peaked at $404K in Q3 2019. 67 funds tracked by Wall St. Rank hold CYCN as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Cyclerion Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 2,255 Cyclerion Therapeutics shares in Q2 2021, an estimated $126K.
  • California Public Employees Retirement System first reported a position in Cyclerion Therapeutics in Q2 2019 and held it in 8 quarters.
  • California Public Employees Retirement System's Cyclerion Therapeutics position peaked at $404K in Q3 2019.
  • 67 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.